Nicole LaBrosse
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Halozyme Therapeutics, Inc. (HALO) | Senior Vice President, Chief Financial Officer | $604,188 | $4,578,814 |
| 2024 | Halozyme Therapeutics, Inc. (HALO) | Senior Vice President, Chief Financial Officer | $568,188 | $4,218,276 |
| 2023 | Halozyme Therapeutics, Inc. (HALO) | Senior Vice President, Chief Financial Officer | $546,188 | $3,849,419 |
| 2022 | Halozyme Therapeutics, Inc. (HALO) | Senior Vice President, Chief Financial Officer | $467,836 | $2,683,103 |
Executive changes
Earnings-call appearances
-
Halozyme 4Q and FY 2025 Financial and Operating Results Conference Call2026-02-17
Halozyme Therapeutics, Inc. (HALO)
-
Investor Conference Call2026-01-28
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-03
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-05
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q1 FY2025 Earnings Call2025-05-06
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q4 FY2024 Earnings Call2025-02-18
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Investor Conference Call2025-01-08
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q3 FY2024 Earnings Call2024-10-31
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-06
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-07
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q4 FY2023 Earnings Call2024-02-20
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-06
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-08
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-09
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q4 FY2022 Earnings Call2023-02-21
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-08
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-09
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-10
Halozyme Therapeutics, Inc. (HALO)
-
Halozyme Therapeutics, Inc. Q4 FY2021 Earnings Call2022-02-22
Halozyme Therapeutics, Inc. (HALO)